Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Nov 19 2015

Chondrosarcoma

Introduction
  • Malignant chondrogenic lesions can occur in two forms 
    • primary chondrosarcoma
      • which includes
        • low-grade, high-grade, de-differenitated chondrosarcoma
        • clear cell chondrosarcoma (see below)
        • mesenchymal chondrosarcoma (see below)
    • secondary chondrosarcoma
      • arises from benign cartilage lesions including 
        • osteochondroma (<1% risk of malignant transfomation)
        • multiple hereditary exostosis (1-10% risk of malignant transfomation)
        • enchondromas (1% risk of malignant transfomation)
        • Ollier's disease (25-40% risk of malignant transfomation)
        • Maffucci's (100% risk of malignant transfomation)
  • Age & location
    • typically, chondrosarcomas are found in older patients (40-75 yrs)
    • there is a slight male predominance
    • most common locations include the pelvis, proximal femur, scapula 
    • tumor location is important for diagnosis as the same histology may be diagnosed as benign in the hand but malignant if located in the long bones
  • Grade
    • 85% of chondrosarcomas are grade 1 or 2
    • 15% of chondrosarcomas are grade 3 or dedifferentiated chondrosarcoma 
      • de-differentiated chondrosarcomas are high grade lesions which develop from low grade chondroid lesions
  • Prognosis
    • axial and proximal extemity lesions have a more aggressive course
    • histologic grade correlates with survival
      • Grade I: 90% survival
      • Grade II: 60-70% survival
      • Grade III: 30-50% survival
      • De-differentiated chondrosarcoma: 10% survival
    • increased telomerase activity in chondrosarcoma, as determined by reverse transcriptase-polymerase chain reaction (RT-PCR), has been shown to directly correlate with the rate of recurrence  
  • Chondrosarcoma sub-types
    • clear cell chondrosarcoma 
      • malignant immature cartilaginous tumor accounting for <2% of all chondrosarcomas
      • most common in 3rd and 4th decades of life
      • commonly presents with insidious onset of pain 
      • presents as an epiphyseal lesion and can be mistaken for low-grade chondroblastoma
      • locally destructive with potential to metastasize 
    • mesenchymal chondrosarcoma
      • chondrosarcoma variant which presents with a biphasic pattern of neoplastic cartilage with associated neoplastic small round blue cell component
      • occurs in younger patients than typical chondrosarcomas
      • may occur at several discontinuous sites at presentation and can occur in the soft tissues
      • treatment includes neo-adjuvant chemotherapy followed by wide surgical resection
Presentation
  • Symptoms
    • pain is the most common symptom
    • may present with slowly growing mass or symptoms of bowel/bladder obstruction due to mass effect in the pelvis
    • 50% of de-differentiated chondrosarcomas present with a pathologic fracture
Imaging
  • Radiographs
    • lytic or blastic lesion with reactive thickening of the cortex 
      • low-grade chondrosarcomas show
        • similiar appearance to enchondromas with additional cortical thickening/expansion and endosteal erosion  
      • high-grade chondrosarcomas show
        • cortical destruction and a soft tissue mass
    • intra-lesional "popcorn" mineralization  may be seen 
      • described as rings, arcs, and stipples of mineralization
    • de-differentiated chondrosarcomas radiographically show a lower grade chondroid lesion with superimposed highly destructive area consistent with the high grade transformed dedifferentiated chondrosarcoma  
  • MRI or CT
    • helpful to determine cortical destruction, marrow involvement, and the soft tissue involvement 
  • Bone scan
    • is usually very hot in all grades of chondrosarcoma
Histology
  • Chondrosarcoma
    • needle biopsy is not indicated for cartilage tumors due to difficulties with diagnosis
      • it is often difficult to determine malignancy based on histology alone
    • chararcteristic histology
      • low-grade chondrosarcomas show
        • few mitotic figures with a bland histologic appearance
        • enlarged chondrocytes with plump multinucleated lacunae  
      • high-grade chondrosarcomas show 
        • hypercellular stroma consisting of characteristic "blue-balls" of a cartilage lesion which permeate the bone trabeculae 
    • enchondromas of hand, Ollier's disease, Maffucci's disease, periosteal chondromas, and chondrosarcoma may all have similar histology
  • De-differentiated chondrosarcomas
    • characterized by a bimorphic histology
      • low grade chondroid component
      • high grade spindle cell component (similiar histology to osteosarcoma, fibrosarcoma, MFH)  
Treatment
  • Operative
    • intra-lesional curettage 
      • indications
        • Grade 1 lesions 
        • treatment of grade 1 lesions located in the pelvis or axial skeleton is controversial
          • many authors recommend wide excision of all chondrosarcomas (even grade 1) if located in the pelvis
    • wide surgical excision      
      • indications
        • grade 2 or 3 lesions
        • some say grade 1 lesions in pelvis
      • historically, there is no significant role for radiation or chemotherapy in typical intramedullary chondrosarcoma 
    • wide surgical excision combined with multi-agent chemotherapy 
      • indications
        • mesencymal chondrosarcoma
        • the role of chemotherapy in de-differentiated chondrosarcoma is very controversial
Differentials & Groups
 
Malignant lesion in older patient(1)
 
May have similar chondrogenic histology
 
Sacral lesions in older patients
 
Treated with wide resection alone (2)
Chondrosarcoma
 
 
 
Metastic disease
     
   
Lymphoma
     
   
Myeloma
     
   
MFH
     
   
Secondary sarcoma
           
Enchondroma / Olliers / Marfuccis    
       
Periosteal chondroma    
       
Osteochondroma (MHE)    
       
Parosteal osteosarcoma            
Adamantinoma            
Chordoma        
 
Squamous cell(3)        
 
ASSUMPTIONS: (1) Older patient is > 40 yrs; (2) assuming no impending fracture (3) assuming no squamous cell metastatic disease
 
IBank
 
Location
Xray
Xray
CT
B. Scan
MRI
MRI
Histo(1)
Case A scapula
 
 
 
Case B femur
 
 
 
Case C pelvis
 
 
Case D tibia
 
 
 
Case E prox femur
 
 
 
Case F prox. humerus
 
 
 
Case H pelvis (dedifferentiated)
 
 
 
Case I femur (dedifferentiated)
 
 
 

(1) - histology does not always correspond to case

 

Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options